With 215 deals in total through Q3, this year is on track to be on par with 2020’s M&A activity. Private Equity activity in the market made up 34% of all deals year-to-date. 

Despite the increased number of deals through Q3, disclosed M&A deal value accounted for only $25B in total. 


In terms of top acquirers of HealthTech, 8 of the top buyers were PE firms. The Carlyle Group, TPG and Main Capital led the pack, scoring 4 acquisitions, as did aggregator Constellation. Following were 5 PE firms: Clearlake Capital and Riverside with 3 acquisitions each, Battery, Providence Equity Partners and Bain Capital close behind with 2 deals each. HealthCatalyst, the only strategic in the list, had 2 deals.